# Brain GABA Levels and Treatment Response in Major Depressive Disorder

> **NCT00464711** · PHASE4 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 40 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Escitalopram

## Key facts

- **NCT ID:** NCT00464711
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-01-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00464711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00464711, "Brain GABA Levels and Treatment Response in Major Depressive Disorder". Retrieved via MORVS 2026-10-14 from https://api.morvs.ai/clinical/NCT00464711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*